SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-074760
Filing Date
2022-03-14
Accepted
2022-03-14 17:15:47
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 d299747ds3.htm S-3 454552
2 EX-1.2 d299747dex12.htm EX-1.2 188920
3 EX-4.4 d299747dex44.htm EX-4.4 277864
4 EX-4.6 d299747dex46.htm EX-4.6 95211
5 EX-4.7 d299747dex47.htm EX-4.7 96845
6 EX-4.8 d299747dex48.htm EX-4.8 83313
7 EX-5.1 d299747dex51.htm EX-5.1 30563
8 EX-23.2 d299747dex232.htm EX-23.2 1647
9 EX-FILING FEES d299747dexfilingfees.htm EX-FILING FEES 42396
10 GRAPHIC g299747dsp097.jpg GRAPHIC 3252
11 GRAPHIC g299747g0311084525522.jpg GRAPHIC 5699
12 GRAPHIC g299747g0311084526444.jpg GRAPHIC 5558
13 GRAPHIC g299747g0311084526819.jpg GRAPHIC 5854
  Complete submission text file 0001193125-22-074760.txt   1300997
Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-263541 | Film No.: 22737559
SIC: 2836 Biological Products, (No Diagnostic Substances)